Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiko Shibamoto

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2025
Imaging-Based Surveillance of Gastroesophageal Varices in Fontan-Associated Liver Disease: Toward a Noninvasive StrategyTadashi Namisaki, Akihiko Shibamoto, Kosuke Kaji, et al.
BMC Gastroenterology|March 8, 2022
Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case reportMisako Tanaka, Hideto Kawaratani, Ryuichi Noguchi, et al.
International Journal of Molecular Sciences|April 27, 2024
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer MicroenvironmentTakahiro Kubo, Norihisa Nishimura, Kosuke Kaji, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 11, 2025
Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in murine advanced liver fibrosis by cleaving vWFHiroyuki Masuda, Kosuke Kaji, Norihisa Nishimura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 30, 2026
Nationwide Engagement in an Interdisciplinary eLearning Program on Alcohol Dependence in JapanAkihiko Shibamoto, Tadashi Namisaki, Ryuhei So, et al.
Clinical Journal of Gastroenterology|June 30, 2022
Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case reportHibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, et al.
Cells|March 11, 2023
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC ActivityFumimasa Tomooka, Kosuke Kaji, Norihisa Nishimura, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 5, 2023
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic miceSatoshi Iwai, Kosuke Kaji, Norihisa Nishimura, et al.
The Journal of Nutritional Biochemistry|September 30, 2023
Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxinAkihiko Shibamoto, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Sciences|July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated AngiogenesisNaoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2025
Imaging-Based Surveillance of Gastroesophageal Varices in Fontan-Associated Liver Disease: Toward a Noninvasive StrategyTadashi Namisaki, Akihiko Shibamoto, Kosuke Kaji, et al.
BMC Gastroenterology|March 8, 2022
Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case reportMisako Tanaka, Hideto Kawaratani, Ryuichi Noguchi, et al.
International Journal of Molecular Sciences|April 27, 2024
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer MicroenvironmentTakahiro Kubo, Norihisa Nishimura, Kosuke Kaji, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 11, 2025
Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in murine advanced liver fibrosis by cleaving vWFHiroyuki Masuda, Kosuke Kaji, Norihisa Nishimura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 30, 2026
Nationwide Engagement in an Interdisciplinary eLearning Program on Alcohol Dependence in JapanAkihiko Shibamoto, Tadashi Namisaki, Ryuhei So, et al.
Clinical Journal of Gastroenterology|June 30, 2022
Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case reportHibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, et al.
Cells|March 11, 2023
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC ActivityFumimasa Tomooka, Kosuke Kaji, Norihisa Nishimura, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 5, 2023
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic miceSatoshi Iwai, Kosuke Kaji, Norihisa Nishimura, et al.
The Journal of Nutritional Biochemistry|September 30, 2023
Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxinAkihiko Shibamoto, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Sciences|July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated AngiogenesisNaoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Pageof 4